Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation.
Doyle A, Adeyi O, Khalili K, Fischer S, Dib M, Goldaracena N, Dillon J, Grant D, Cattral M, McGilvray I, Greig P, Ghanekar A, Lilly L, Renner E, Levy G, Selzner N.
Doyle A, et al. Among authors: fischer s.
Liver Transpl. 2016 Sep;22(9):1295-300. doi: 10.1002/lt.24495.
Liver Transpl. 2016.
PMID: 27314458
Free article.
No abstract available.